Clinical Trials Directory

Trials / Completed

CompletedNCT00334503

Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
Sponsor
Sanwa Kagaku Kenkyusho Co., Ltd. · Industry
Sex
All
Age
20 Years – 69 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus treated with Biguanide.

Conditions

Interventions

TypeNameDescription
DRUGMiglitol

Timeline

First posted
2006-06-07
Last updated
2008-10-10

Locations

13 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT00334503. Inclusion in this directory is not an endorsement.